135 filings
ARS
2023 FY
ATHA
Athira Pharma Inc
9 Apr 24
Annual report to shareholders
8:35am
DEFA14A
ATHA
Athira Pharma Inc
9 Apr 24
Additional proxy soliciting materials
8:34am
DEF 14A
ATHA
Athira Pharma Inc
Definitive proxy
9 Apr 24
8:32am
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
S-8
ATHA
Athira Pharma Inc
22 Feb 24
Registration of securities for employees
4:34pm
8-K
jtdyxf
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
o8lld3fv50nwp
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
vd7c xojuq
9 Nov 23
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
sg2n7yhahv76rd9tpjql
10 Aug 23
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
7j6mk1p0rjbn
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
qdsfhyqx8t3 r084ol
11 May 23
Athira Pharma Reports First Quarter 2023 Financial Results
4:11pm
ARS
958crqo q0s
5 Apr 23
Annual report to shareholders
7:19am
DEFA14A
s6g5n
5 Apr 23
Additional proxy soliciting materials
7:18am
S-8
62e10ste tsit
23 Mar 23
Registration of securities for employees
4:36pm